On January 21, 2026, Wuhan Mingde Biological Technology Co., Ltd. (hereinafter referred to as "the Company") issued an announcement regarding the joint investment with professional institutions, with the company planning to increase its registered capital by 300 million RMB to invest in the industry (limited liability). The registered capital will increase from 95 million RMB to 124 million RMB. Specific details can be found on the official website of the Company on January 21, 2026.
1. Overview of External Investment
The registered capital will increase from 95 million RMB to 124 million RMB. The specific situation is as follows: